What is he best known for?
The fields of study he is best known for:
- Enzyme
- Organic chemistry
- Gene
His primary areas of investigation include In vivo, Biomedical engineering, Cancer research, Biophysics and Immunology.
His work deals with themes such as In vitro, PLGA, Molecular biology, Photochemistry and Photodynamic therapy, which intersect with In vivo.
His Biomedical engineering research is multidisciplinary, incorporating perspectives in Biocompatibility, Thrombus and Cell biology.
His research integrates issues of Cancer cell, Cancer immunotherapy, Immune system, Immunotherapy and Antigen in his study of Cancer research.
His Biophysics research incorporates themes from Wound healing, Enzyme, Light Up, Nitric oxide and Analytical chemistry.
His Immunology research includes themes of Endothelial stem cell, Restenosis and Mesenchymal stem cell, Pathology.
His most cited work include:
- Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts (1408 citations)
- Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts. Implications for Cell-Based Vascular Therapy (420 citations)
- Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. (373 citations)
What are the main themes of his work throughout his whole career to date?
Deling Kong mostly deals with In vivo, Biomedical engineering, Biophysics, Cancer research and Cell biology.
His In vivo research incorporates elements of In vitro, Drug delivery, Fluorescence-lifetime imaging microscopy, Photodynamic therapy and Pharmacology.
His Biomedical engineering study integrates concerns from other disciplines, such as Biocompatibility, Calcification and Regeneration.
He has researched Biophysics in several fields, including Nanotechnology, Stereochemistry, Peptide and Cytotoxicity.
His study in Cancer research is interdisciplinary in nature, drawing from both Cytotoxic T cell, Immune system, Antigen and Cancer immunotherapy.
His Cellular differentiation research extends to the thematically linked field of Cell biology.
He most often published in these fields:
- In vivo (34.35%)
- Biomedical engineering (20.35%)
- Biophysics (18.82%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (23.41%)
- Biomedical engineering (20.35%)
- In vivo (34.35%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Biomedical engineering, In vivo, Cell biology and Immune system.
His biological study spans a wide range of topics, including Doxorubicin, Nitric oxide and Cancer immunotherapy.
In the subject of general Biomedical engineering, his work in Scaffold and Tissue engineering is often linked to Degradation, thereby combining diverse domains of study.
Deling Kong has included themes like Calcification, Gene delivery and Injectable hydrogels in his In vivo study.
Cell biology and Macrophage polarization are commonly linked in his work.
The study incorporates disciplines such as Cytotoxic T cell, Primary tumor and Antigen in addition to Immune system.
Between 2019 and 2021, his most popular works were:
- Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses (31 citations)
- Hypoxia-tropic nanozymes as oxygen generators for tumor-favoring theranostics. (20 citations)
- Nitric-Oxide-Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine (19 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Organic chemistry
- Gene
Deling Kong focuses on Cancer research, Cell biology, Regeneration, In vivo and Cancer immunotherapy.
The Cancer research study combines topics in areas such as Immunogenic cell death, Immune system, Immunotherapy and Antigen.
In his study, which falls under the umbrella issue of Cell biology, Cancer cell, Pheophorbide A and Photodynamic therapy is strongly linked to Apoptosis.
His Regeneration research is multidisciplinary, relying on both Cell, Regenerative medicine, Stem cell, Paracrine signalling and Intimal hyperplasia.
His In vivo study incorporates themes from Intracellular parasite, Biofilm, Photosensitizer, Antibacterial therapy and Mesenchymal stem cell.
As a part of the same scientific family, he mostly works in the field of Cancer immunotherapy, focusing on Immunogenicity and, on occasion, Immunization, CTL*, Epitope and Vaccination.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
